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tsm5Twenty-six non-synonymous and synonymous mutations have been identiﬁed in the temperature-sensitive
(ts) mutant (tsm5) of the K181 (Birmingham) variant of murine cytomegalovirus that is deﬁcient in DNA
synthesis, processing and packaging at the non-permissive temperature and produces undetectable levels of
infectious virus in mice. Non-synonymous mutations identiﬁed in the M70 (primase), M56 (terminase) and
M98 (nuclease) ORFs were introduced individually and in combination into the K181 (Perth) variant using
BAC technology to examine their role in the ts phenotype. The M56 (G439R) and M98 (P324S) mutations had
no evident role in the ts phenotype. However, the C890Y M70 mutation alone and in combination with the
M56 and/or M98 mutations rendered the virus ts, unable to replicate in mice and highly defective in DNA
synthesis. Reversion of the tyrosine mutation to cysteine or introduction of C890M (experimentally) or
C890S (naturally) restored the wt phenotype.IntroductionMost current studies aimed at identifying ORFs involved in
important aspects of murine cytomegalovirus (MCMV) biology use
gene knock-outs which identify genes as essential or non-essential for
virus replication and imply in vivo roles for non-essential ORFs.
However, this approach gives little indication of the function of the
gene product or functionally important domains. Targeted mutagen-
esis is a more meaningful approach but targets to be mutated require
prior knowledge. The classical approach, now largely neglected, is to
mutate virus using mutagens and then to identify mutations
associated with the observed phenotype.
Mutant tsm5, created by mutagenesis of the murine cytomegalo-
virus (MCMV) K181 (Birmingham) variant by treatment with N-
methyl-N′-nitro-N-nitrosoguanidine (NTG), is restricted in growth at
40 °C (Sammons and Sweet, 1989). Titres of this mutant were reduced
by ∼4 log10 at 40 °C compared to 33 °C or 37 °C and failed to reach
detectable levels in any tissue of 1-week-old mice for up to 21 days
following i.p. inoculation with 4×103 pfu of virus. Electron micro-ll rights reserved.scopy showed that tsm5 had a defect in DNA encapsidation and
Southern hybridisation indicated that while DNA synthesis was
signiﬁcantly reduced by ∼90% at 40 °C, concatameric DNA was
cleaved into unit length genomes with close to wt efﬁciency (Sweet
et al., 2007). This suggested a defect in DNA replication, processing or
packaging and sequence analysis of genes involved in these processes
identiﬁed three mutations: a C toTmutation leading to G439R residue
change in the putative large terminase subunit (M56); a C to T
mutation (P324S) in the putative alkaline nuclease (M98); and a C toT
mutation (C890Y) in the putative primase component (M70) of the
helicase–primase complex (Sweet et al., 2007).
In this study, these mutations have been introduced individually
and in combination into the K181 (Perth) strain of MCMV using the
K181 MCMV bacterial artiﬁcial chromosome (BAC) to examine their
role in the ts and in vivo phenotype of the virus.
Results
Comparison of K181 (Perth) and K181 (Birmingham) variants
To examine the role of the mutations identiﬁed in tsm5 in its
phenotype mutations were introduced individually and in combi-
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The mutant tsm5 was derived from the K181 (Birmingham)
variant whereas the available K181 BAC was derived from the
K181 (Perth) variant. As it was possible that the two K181
variants would replicate differently it was important to compare
the two. The K181 (Perth) variant was recovered from the K181
(Perth) BAC following transfection of NIH 3T3 cells and passage
in MEFs to remove the BAC. As shown in Fig. 1A the two strains
behaved similarly at 37 °C and 40 °C thus allowing the use of
the K181 (Perth) BAC to examine the role of the tsm5 mutations
in replication.
Production of Mt70890Y, Mt98324S and Mt56439R mutants and
their revertants
These mutant viruses were produced by a two-step Red-
mediated recombination in which the ORF was ﬁrst replaced by an
rpsL-neo cassette and then by the mutated form of the respective
ORF as described in Materials and methods. A further two-step
protocol was required to produce their corresponding revertants
whereby the mutated ORF was replaced by the rpsL-neo cassette
and this in turn was replaced by the wt ORF. Mutant viruses
Mt70890Y, Mt98324S and Mt56439R and their corresponding revertant
viruses Rv70C890, Rv98P324 and Rv56G439 were then derived follow-
ing transfection of the respective MCMV BAC plasmid into NIH 3T3
cells and selection of isolated plaques. Viruses containing BACs were
then passaged, selecting individual plaques each time, to produce
viruses in which the BACs had been excised as conﬁrmed by PCR
and sequencing. To remove the BACs required between 3 and 6
passages and was facilitated by homologous recombination between
249 bp of MCMV sequence ﬂanking both ends of the BAC cassette
(Redwood et al., 2005).Fig. 1. Growth curves of parental viruses and single mutants in tissue culture. Virus mean titr
with anMOI of 0.05 for (A) K181 B'ham (■,□) and K181 Perth (●,○) at 37 °C ∼■,●) and 40
Mt98324S (■,□) and Rv98P324 (●,○) at 37 °C (■,●) and 40 °C (□,○); and (D) Mt70890Y (■,
replicates in a typical growth curve is shown, for (D) the results are the means±SD of 3 inThe strategy used to conﬁrm the correct structure of the
constructed BACs is shown for the mutant Mt56439R in Fig 2. This
analysis was done at each step of the procedure and for the ﬁnal
isolated mutant or revertant. Further conﬁrmation that no unex-
pected rearrangements had taken place was obtained using
restriction fragment polymorphism analysis with HpaI (Fig. 3).
This pattern agreed well with the theoretical RFLP pattern. Other
enzymes tested include EcoRI, AseI, and DraI (data not shown).
Sequencing demonstrated that the correct mutation had been
introduced (data not shown).
Replication kinetics of viruses in tissue culture
Mutants Mt56439R and Mt98324S showed the wt phenotype when
examined over 9 days at 37 °C and 40 °C (Figs. 1B and C). Both viruses
showed similar growth kinetics at 37 °C and yields were reduced by
∼10 fold at 40 °C. No signiﬁcant differences in growth kinetics were
observed for the corresponding revertant viruses Rv56G439 and
Rv98P324 (Figs. 1B and C).
In contrast, mutant Mt70890Y was temperature-sensitive (Fig. 1D).
Its growth at 37 °C was similar to Mt56439R and Mt98324S and to
revertant Rv70C890 but it replicated poorly at 40 °C and this
replication was considerably delayed until days 8–9 when titres of
1.0–2.0 log10 pfu/ml were detected. Although yields varied some-
what at 40 °C between experiments the results shown in Fig. 1D,
which are the means±SD of 3 separate experiments, clearly
demonstrate that Mt70890Y is temperature-sensitive. Sequencing
showed that the virus isolated at 9 days post infection was still
mutant (data not shown). One of these experiments, in which titres
were relatively high, was continued up to 21 days post infection
(Fig. 4A); yields only reached a maximum of 2.8 log10 pfu/ml and
virus remained mutant (data not shown).es (log10 pfu/ml±SD) from 0–9 days post infection (−1 day represents inoculum titre)
°C (□,○); (B) Mt56439R (■,□) and Rv56G439 (●,○) at 37 °C (■,●) and 40 °C (□,○); (C)
□) and Rv70C890 (●,○) at 37 °C (■,●) and 40 °C (□,○). For (A)–(C) the mean±SD of 3
dividual experiments each with 3 replicates.
Fig. 2. PCR conﬁrmation of rpsL-neo cassette insertion in the M56 gene of theMCMV BAC and its replacement with mutatedM56 to produce themutant Mt56439R BAC. (A) Schematic
representation of the primer binding sites. Viral primers are shown in solid arrows, rpsL-neo primers are shown in broken arrows. (B) PCR products obtained with primer sets a+b
and b'+a' in lanes 1 and 2 indicated the correct rpsL-neo cassette insertion into the targeted gene. No PCR products obtained with primer sets a+c and c'+a' in lanes 3 and 4
indicated the absence of the corresponding wt ORF in the BAC. Positive ((+)ve) and negative ((−)ve) controls for primer sets a+c and c'+a' are shown in lanes 5–6 and 7–8,
respectively. (C) PCR products obtained with primer sets a+c and c'+a' in lanes 1 and 2 indicated reinsertion of viral DNA sequence in the targeted gene. No PCR products obtained
with primer sets a+b and b'+a' in lanes 3 and 4 indicated the absence of the rpsL-neo cassette in the BAC. Positive ((+)ve) and negative ((−)ve) controls for primer sets a+b and
b'+a' are shown in lanes 5–6 and 7–8, respectively. Molecular size markers (lanes M), in kilobases, are indicated.
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their revertants
Mutant Mt70890Y is thus temperature-sensitive and shows
similar replication kinetics to tsm5 at 40 °C. However, different
stocks of tsm5 are mixtures of mutants and show allelic
polymorphism in their M56, M98 and M70 mutations with either
mutant nucleotide, wt nucleotide or both (Timoshenko et al.,
2009). It was thus possible that other mutations were modifying
the effect of the M70 mutation in tsm5. To examine this, a double
mutant containing the M70 and M98 mutations (Mt98324S70890Y)
and a triple mutant (Mt98324S70890Y56439R) containing all 3Fig. 3. Restriction fragment analysis of mutant and revertant BAC genomes. Mutant, revertant
and resulting fragments were separated on a 0.4% agarose gel for ∼19 h at 2 V/cm. Molecumutations were constructed together with their revertants. As
this involved up to 6 recombination events for the triple mutant
care was taken to analyse each virus for correct construction, lack
of DNA rearrangement and inserted mutation at each step as
described above (data not shown).
Mutant Mt98324S70890Y replicated similarly to mutants Mt70890Y
and Mt98324S and to its corresponding revertant, Rv98P32470C890, at
37 °C and showed similar poor yields to mutant Mt70890Y at 40 °C
(Fig. 4B). This experiment was repeated 3 times, each time with 3
replicates. In one of the replicates, virus titres were higher than in
the other 8 replicates, reaching yields of 3.4 log10 pfu/ml by day 9
post infection (data not shown). Interestingly, this virus hadandwt K181 (Perth) BAC DNA (∼2 μg) was digestedwith 1 μl of HpaI restriction enzyme
lar size markers (lanes M), in kilobases, are indicated.
Fig. 4.Growth curves of mutant viruses in tissue culture. Virus mean titres (log10 pfu/ml) from 0 to 9 or 21 days post infection (−1 day represents inoculum titre) with anMOI of 0.05
for (A) Mt70890Y (■, □) and Rv70C890 (●, ○) at 37 °C (■, ●) and 40 °C (□, ○), (B) Mt98324S70890Y (■, □) and Rv98P32470C890 (●, ○) at 37 °C (■, ●) and 40 °C (□, ○); and
(C) Mt98324S70890Y890S56439R (■, □) and Rv98P32470C89056G439 (●,○) at 37 °C (■, ●) and 40 °C (□,○). For (A) the mean±SD of 3 replicates in a typical growth curve is shown, for
(B) and (C) the results are the means±SD of 2 individual experiments each with 3 replicates.
Fig. 5. Sequencing over nucleotide position 99,286 of the M70 gene in the stock of the
serine triple mutant (Mt98324S70890S56439R) virus grown at 37 °C and one of the
replicates of this virus at the end of the growth curve at 37 °C and 40 °C. Total DNAwas
isolated from virus-infected cells, M70 gene fragment PCR ampliﬁed and sequenced.
The original mutation T is replaced with the new mutation G partially at 37°C and
completely at 40 °C.
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post infection but the M98 ORF remained mutant. Continuing the
experiment for the 6 replicates in the other 2 experiments for up to
21 days post infection showed that yields did not increase and the
viruses remained temperature-sensitive with no reversion (Fig. 4B).
In contrast, the initial experiment with the triple mutant
Mt98324S70890Y56439R showed considerably improved growth at
40 °C compared to the other mutants, reaching titres of ∼4 log10
pfu/ml by 8 days post infection (Fig. 4C). This experiment was
repeated with similar results (results in Fig. 4C are the means±SD of
the 2 experiments). Interestingly, sequencing showed that in all 6
replicates the virus had further mutated from the mutant UAC (ATG
on complementary strand) tyrosine codon to the mutant UCC (AGG
on complementary strand) serine codon in M70 and, as early as
1 day post infection at 40 °C, the virus was a mixture
(Mt98324S70890Y/890S56439R) while by 9 days post infection the
Fig. 6. Real-time PCR quantiﬁcation of MCMV DNA. MEF cells were infected with K181 Perth (x), Mt70890Y (●), Mt98324S70890Y (▴), Mt98324S70890Y56439R (♦),
Mt98324S70890Y/890S56439R (■), Rv70C890 (○), Rv98P32470C890 (△) or Rv98P32470C89056G439 (◊) at an MOI of 0.05 pfu per cell and incubated at 37 °C (A) and 40 °C (B). Results are
the mean±SD of two to ﬁve separate experiments.
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Furthermore, the virus that emerged at 37 °C was also a mixture of
viruses containing the M70 serine and tyrosine mutations although
the latter greatly predominated (Fig. 5). These results strongly
suggest that the M70 serine mutation had occurred during produc-
tion of virus working stock although this could not be detected
by sequencing as the virus inoculum contained only virus with
M70 tyrosine.
Two further transfections were performed with the Mt98324S
70890Y56439R BAC construct which produced 3 different virus stocks.
All 3 viruses contained the M70 tyrosine mutation (as determined
by sequencing) and had similar growth properties to Mt70890Y and
Mt98324S70890Y viruses (data not shown).
DNA kinetics
The effect of the M70mutation on DNA synthesis was examined in
virus-infected cells at 37 °C and 40 °C from 1 to 9 days post infection
using real-time PCR as described in Materials and methods. TheFig. 7.MCMV titres and DNA copy number in the salivary glands of BALB/cmice. BALB/cmice
were sacriﬁced, the salivary glands collected, homogenised, clariﬁed by centrifugation and the
cell pellets and genome copy number measured by real-time PCR (B). Each symbol represen
limit of detection (indicated by long thin lines) was 100 (Mt70890Y]) and 1000 (M98324S70890
thick lines indicate mean values. Values below the limit of detection are not shown.kinetics of DNA synthesis at 37 °C was essentially similar for all viruses
examined (Fig. 6A) increasing ∼104–105 fold by 3 days post infection
and maintaining these levels up to day 9 post infection. The kinetics
were similar for K181 (Perth), Rv70C890, Rv98P32470C890 and
Rv98P32470C89056G439 viruses at 40 °C and similar to that at 37 °C
(Fig. 6B). In contrast, DNA synthesis was markedly reduced in
Mt70890Y, Mt98324S70890Y and Mt98324S70890Y56439R virus-infected
cells at 40 °C (∼100–1000 fold) at day 1 post infection. It is possible
that the delayed DNA kinetics at later time points may be due
indirectly to other blocks in virus replication but this is unlikely as the
revertant virus, in which only the primase mutation had been
repaired, has wt DNA levels at all time points indicating no other
defects in the replication cycle. Interestingly, DNA synthesis in the
serine mutant Mt98324S70890Y/890S56439R virus-infected cells was
similar to that of the other M70890Y containing mutants initially
(day 1) but gradually increased to similar levels to K181 (Perth) and
revertant viruses by day 9 (Fig. 6B). These results agree well with
those for virus yields and show that the major defect in Mt70890Y is its
inability to synthesise DNA at the non-permissive temperature.were inoculated intraperitoneallywith 104 pfu of virus. At 21 days post infection animals
supernatant titrated for virus (A) while total DNAwas extracted from the salivary gland
ts a mouse. Numbers 1, 2, 3 and 4 correspond to the particular animal in the group. The
Y]) pfu per salivary gland in (A) and 105 MCMV genomes per salivary gland in (B). Short
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Infectious virus was readily detected in the salivary glands of
BALB/c mice inoculated with revertant viruses Rv70C890 and
Rv98S32470C890 or the wt K181 (Perth) variant and examined
21 days post infection (Fig. 7A). The mean viral titre for Rv70C890
was 104.9 pfu/salivary gland; the mean viral titres for Rv98S32470C890
and wt K181 (Perth) were lower at 104.1 and 104.6 pfu/salivary gland
but these differences were not signiﬁcant (P N0.05). In contrast, no
infectious virus was detected in mice inoculated with mutants
Mt70890Y or Mt98324S70890Y (Fig. 7A). In agreement with the
infectivity assays, the average number of viral genomes per salivary
gland 21 days post infection, as estimated by real-time PCR, were
similar for revertant and wt K181 (Perth) virus being 108.8, 107.3 and
107.9 respectively for Rv70C890, Rv98P32470C890 and wt (Fig. 7B). DNA
was difﬁcult to detect in mice infected with either mutant but the data
presented in Fig. 7B indicate that at least 1 animal in each group had
detectable DNA but these levels were at least 6300 fold lower for
mutant Mt70890Y than for revertant Rv70C890. Thus mutants contain-
ing the M70 tyrosine mutationwere also attenuated for salivary gland
replication in mice.
Discussion
Twenty-six mutations have now been identiﬁed in MCMV mutant
tsm5 (Sweet et al., 2007; Timoshenko et al., 2009), sixteen of which
result in an amino acid change. Previous studies have demonstrated
that different virus stocks of tsm5 are different mixtures of mutants
resulting in polymorphisms in at least 6 loci, ORFs M27, M36, M53,
M56, M70 and M98 (Sweet et al., 2007; Timoshenko et al., 2009).
However, the relative proportion of each mutant within the virus
stock varies. Thus, the identiﬁed amino acid may be either mutant, wt
or both (Timoshenko et al., 2009). One or more of these identiﬁed
mutations could contribute to the tsm5 phenotype as they are in genes
identiﬁed as having a role in DNA synthesis, cleavage and packaging
(Pari and Anders, 1993; Homa and Brown, 1997). Three of these have
been examined in the present study.
TheM56 ORF encodes the putative terminase subunit which, in the
herpes simplex type 1 (HSV-1) UL28 homologue, associates with the
putative ATPase subunit of the terminase (UL15; MCMV M89) and is
involved in inserting viral DNA into virion capsids and cleavage of DNA
concatemers into unit length genomes (Tengelsen et al., 1993; Bogner
et al., 1998). The tsm5 G439R mutation does not fall within the region
containing the putative ATP-binding pocket (Scholz et al., 2003),
shown to be essential for terminase activity (Wang andMcVoy, 2008),
or any other known functional domains of the terminase. It is located
within the variable “spacer” region that is poorly conserved even
among cytomegaloviruses, indeed deletion of 13 of the 68 amino acids
in HSV-1 UL28 had no effect on virus growth or DNA packaging
(Abbotts et al., 2000). In conﬁrmation of this, mutant Mt56439R had a
wt replication phenotype in MEF cells at both 37 °C and 40 °C (Fig. 1B).
Surprisingly, Mt98324S mutant virus also exhibited a wt pheno-
type (Fig. 1C). The wt proline 324 is highly conserved in motif IV of
the seven herpesvirus alkaline nuclease motifs deﬁned by Goldstein
and Weller (1998). The nuclease activity of the HSV-1 UL12 protein
(M98 homologue) has an important function in resolving branches
formed from intra- and inter-molecular recombination of large
branched head-to-tail concatemers formed during DNA replication
(Reuven et al., 2003). Clearly proline 324 is not an essential residue
for this function.
In contrast, the C890Y mutation in M70 has a very important role
in the tsm5 phenotype as viruses containing this mutation (Mt70890Y,
Mt98324S70890Y and Mt98324S70890Y56439R) all replicated poorly at the
non-permissive temperature and reversion of tyrosine 890 to the wt
cysteine, serine or methionine restored the wt phenotype. The HCMV
UL70 homologue, together with UL102 and UL105, are predicted toencode proteins that comprise the helicase–primase complex essen-
tial for DNA replication (McMahon and Anders, 2002). Like the HSV-1
primase, HCMV pUL70 contains highly conserved putative DxD and
zinc ﬁnger motifs (Woon et al., 2008). Recently, other motifs have also
been recognised in UL70 including a putative protein disulphide
isomerase CxC motif, a cAMP-dependent protein kinase phosphoryla-
tion site, 20 casein kinase II phosphorylation sites, 10 protein kinase C
phosphorylation sites and 2 tyrosine kinase phosphorylation sites
(Woon et al., 2008). None of these encompass residue 890.
Without a structure it is difﬁcult to know how the C890Y mutation
affects primase function. The cys–his–cys–cys zinc ﬁnger motif is
conserved in all herpesviruses and is involved in DNA binding and
helicase activity as well as primase activity as mutations within this
motif of the HSV-1 homologue of M70/UL70 affects these functions
(Chen et al., 2005). The C890 residue is conserved in all cytomega-
loviruses and is located 16 amino acids upstream of the zinc ﬁnger
suggesting that it toomay affect all 3 activities. The replacement of the
cysteine with a tyrosine may have introduced a tyrosine kinase
phosphorylation site and the phosphorylated tyrosine could markedly
affect primase conformation and stability. However, the ScanProsite
software from the Expert Protein Analysis System (ExPASy) proteo-
mics server did not identify Y890 as a predicted tyrosine kinase
phosphorylation site. Both cysteine and tyrosine provide chemically
active side chains for interaction with other amino acids and the large
side chain of tyrosine could sterically destabilise the primase protein
structure. Replacement of cysteine with serine, a much smaller amino
acid with a chemically active side chain restored wt activity. However,
replacement of cysteine with methionine, a relatively inactive amino
acid, also restored wt activity (data not shown) suggesting that the
ability of amino acid residue 890 to interact chemically with other
amino acids in the structure is not important.
The polymorphism in tsm5 was unexpected. It is possible that
the polymorphism resulted from reversion but this is unlikely as
different stocks of tsm5 varied in their polymorphic loci and wt
virus did not emerge on passage. A more likely explanation is the
production of multicapsid virions. During the production of tsm5
precautions were taken to try and eliminate multicapsid virions,
which are produced in tissue culture (Hudson et al., 1976; Chong
and Mims, 1981; Weiland et al., 1986) and in vivo (Reddehase et al.,
1985), by plaque picking, sonication and ﬁltration (Sammons and
Sweet, 1989). However, it now seems likely that this was not
achieved. Multicapsid virions consist of up to 15 capsids or virions
surrounded by a single membrane (Chong and Mims, 1981) and up
to 40% of virions may be multicapsids (Kurz et al., 1997).
Furthermore, recent studies suggest that 80 to 500 MCMV genomes
may be required to form a single plaque (Kurz et al., 1997; Heider
et al., 2002) and, owing to the defective nature of mutant virus, up
to 300 times more virions may be required for one pfu of mutant
virus (Heider et al., 2002). Functional trans-complementation
between mutant and wt MCMV viruses following co-infection of
the same cell has been shown in vivo (Cicin-Sain et al., 2005) and
such a mechanism may maintain the tsm5 polymorphism. Thus it
may be very difﬁcult to plaque purify single cloned mutants from
such a heterogeneous mix. An inability to plaque purify a pure
clone was shown for HCMV isolate TB40/E (Dolan et al., 2004;
Sinzger et al., 2008). Subsequent cloning of TB40/E as a BAC was
necessary to produce a genetically pure clone for phenotypic
analysis (Sinzger et al., 2008). This method could be applied to
separate genetically different variants of tsm5 for subsequent
analysis of their phenotypes.
The above data demonstrates that the M70 tyrosine mutation is
the ﬁrst ts mutation identiﬁed in tsm5 and that this mutation also
attenuates replication in vivo. However, previous studies with the
chimaeric virus Smith/tsm5DGIK, constructed from overlapping
cosmids and containing region M56-m144 from tsm5 and its 5′
and 3′ ends from the Smith strain of MCMV (Sweet et al., 2007),
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tsm5. This contradicts present data as the chimaeric virus is expected
to contain the M70 mutation. However, as tsm5 is polymorphic the
chimaeric virus was sequenced over known mutations to examine
the possibility that the M70 mutation may not be present.
Sequencing conﬁrmed mutations in M56 and M98 ORFs but revealed
that M70 was wt. Thus, its ability to replicate in mice may be due to
the wt M70 gene and not to the Smith component as previously
suggested (Sweet et al., 2007). Interestingly, many of the other tsm5
mutations are also absent in Smith/tsm5DGIK suggesting that the
M70 may not be the only mutation contributing to the tsm5
temperature-sensitive phenotype. This emphasises the difﬁculty of
determining the contribution of speciﬁc mutations to a phenotype
when multiple mutations are present and constitute only single
nucleotide changes. This is made more difﬁcult when they are
subject to change in different virus stocks.
A ﬁnal puzzle is why the Mt70890Y and Mt98324S70890Y mutant
viruses were attenuated for salivary gland replication in mice. This is
unlikely to be due to their temperature-sensitivity at 40 °C as mice
have a normal body temperature of 37 °C. It is possible that the
mutation produces a generally “stressed” virus, which is reﬂected by
decreased replication at elevated temperature in vitro and by the in
vivo environment of mice.
In conclusion, a single nucleotide change resulting in a cysteine to
tyrosine amino acid change in the M70 primase of MCMV renders the
virus temperature-sensitive and attenuated for salivary gland replica-
tion in mice. Whether a similar change in the conserved cysteine of
HCMV produces a similar phenotype is currently under investigation.
Materials and methods
Cells and viruses
The K181 (Birmingham) variant of MCMV and mutant tsm5 have
been described previously as has the method of production of primary
mouse embryo ﬁbroblasts (MEFs) and virus stocks (Sammons and
Sweet, 1989; Sweet et al., 2007). The K181 (Perth) variant of MCMV
was kindly provided by Dr. Alec Redwood, Perth, Australia as a BAC
containing the K181 (Perth) viral genome. Viral titres were quantiﬁed
in MEF cells by standard plaque assays.
PCR ampliﬁcation
The standard PCR reactionwas carried out with 300 ng of DNA in a
50 μl PCR reaction using 2×ReddyMix™ PCRmaster mix (Abgene). An
initial denaturing step of 2 min at 94 °C was followed by 30
ampliﬁcation cycles of 94 °C for 45 s, 50–70 °C (depending on primer
melting temperature) for 45 s and 72 °C for up to 3 min depending on
the length of the expected PCR product. The PCR reaction was
completed with an extra extension time of 7 min at 72 °C before
cooling down to 4 °C. PCR products used in mutagenesis were
ampliﬁed with Extensor Hi-Fidelity PCR Master Mix (Abgene). An
initial denaturing step of 3 min at 94 °C was followed by 10
ampliﬁcation cycles of 94 °C for 45 s, 60 °C for 30 s and 72 °C for
1 min, then 19 ampliﬁcation cycles of 94 °C for 45 s, 60 °C for 30 s and
72 °C for up to 3min depending on the length of expected PCR product
and ﬁnal extension step of 7 min at 72 °C before cooling down to 4 °C.
Sequencing
PCR products, puriﬁed using the QIAquick PCR Puriﬁcation kit
(Qiagen), were sequenced using the Big Dye™ terminator ready
reaction cycle sequencing kit (Applied Biosystems) and an ABI 3700
machine. The entire M56, M70 and M98 gene sequences were
assembled by comparison to the K181 (Perth) consensus sequences
(Redwood et al., 2005) using the NCBI BLAST network servicetranslated using Alltrans and the whole protein sequence for each
gene aligned using CLUSTALW.
Plasmids
Plasmids pRpsL-neo and pKD46 were obtained from Gene Bridges,
Dresden, Germany.
Quantitative real-time PCR
Total genomic DNA from virus-infected MEF cells or homogenised
salivary glands of virus-infected BALB/c mice was prepared using the
DNeasy blood and tissue kit (Qiagen), according to the manufacturer's
instructions. All real-time PCRs were performed in an ABI Prism 7000
Sequencing Detection System (Applied Biosystems) in 96-well clear
plates (Applied Biosystems). Primers and probes were designed using
the TaqMan primer and probe design software and synthesised by
Eurogentec. The target MCMV gene was m29.1 and forward and
reverse primers and probes were as follows (5′→3′): forward,
GAAATGCACACGGAAAAAAAGC; reverse, ATCGTATGAGTAGTGGG-
CGTTTCT; probe, FAM-TACCCGAATGGCTTTATGCCATTGCC-BHQ1. Simi-
larly, the forward and reverse primers and the probe for the mouse
GAPDH gene used as a control were (5′→3′): forward, AAGA-
GAGGCCCTATCCCAACTC; reverse, TAGGCCCCTCCTGTTATTATGG;
probe, Yacima Yellow-TCTCCCTCACAATTTCCATCCCAGACC-BHQ1. The
PCR reactions were performed in a 20-μl volume containing 10 μl of
qPCRMastermix (Eurogentec), 450 nM of each primer, 187.5 nM of the
probe and 3–5 μl of the DNA sample. For thermal cycling, conditions
consisted of two initial steps of 2 min at 50 °C and 10 min at 95 °C,
followed by 44 ampliﬁcation cycles (15 s at 95 °C, 1 min at 60 °C).
Threshold Cycle (CT) was determined as a cycle number at which the
ﬂuorescence generated in the reaction crosses the threshold set
within the logarithmic phase of each PCR. For relative quantiﬁcation of
MCMV genomes in virus-infectedMEF cells the CT for the control gene
was subtracted from the CT for the gene of interest and the relative
amount of that gene was calculated as 2−ΔCT. For absolute
quantiﬁcation of MCMV genomes in salivary glands of virus-infected
BALB/cmice,10-fold serial dilutions containing 109 to 0 copies of K181
(Birmingham) virion DNA per assay were tested in triplicate and used
to construct the standard curve by plotting the average CT values
against the logarithm of MCMV genome copy number, followed by
least-squares linear regression analysis. MCMV genome copy number
per known amount of DNA used in the PCR reaction was calculated
using the equation obtained from the regression analysis. Data were
further processed to determine the number of MCMV genomes per
salivary gland. The limit of detection of this assay was determined as
400 MCMV genomes per PCR reaction or 105 MCMV genomes per
salivary gland.
BAC mutagenesis
A two-step Red-mediated homologous recombination was per-
formed to introduce mutations into the M56, M70 and M98 genes and
to revert them to wt. Selection of recombinants is facilitated using an
rpsL-neo cassette, the rspL gene conferring streptomycin sensitivity
and the neo gene kanamycin resistance. Escherichia coli DH10B (which
has a mutation in its rpsL gene rendering it streptomycin resistant)
containing the K181 (Perth) MCMV bacterial artiﬁcial chromosome
(BAC) (chloramphenocil resistant) (Redwood et al., 2005) was
transformed with plasmid pKD46, which expresses λ phage recombi-
nases redα, redβ and gam (Datsenko and Wanner, 2000), and grown
at 30 °C to OD600 of 0.3 on LB medium containing 12 μg ml−1
chloramphenicol and 50 μg ml−1 carbenicillin at which point the
expression of Red recombinases was induced by adding L-arabinose to
a ﬁnal concentration of 0.35%. The cultures were incubated at 37 °C for
1 hwith shaking andwere then harvested at 13,000 ×g at 4 °C for 30 s.
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A linear DNA fragment (1.3 kb) containing a streptomycin
sensitive and kanamycin resistant rpsL-neo cassette ﬂanked at the
5′ end with 52 nt of the M56 ORF (nt 86,484 to 86,535; based on
K181 (Perth) genomic sequence, GenBank database accession
number AM886412), the M70 ORF (98,989 to 99,040) or the M98
ORF (142,813 to 142,864) and at the 3′ end with 51 nt of the M56 ORF
(nt 87,035 to 87,085), the M70 ORF (99,540 to 99,590) or the M98
ORF (143,365 to 143,415) was ampliﬁed by PCR from the pRpsL-neo
plasmid template using Extensor Hi-Fidelity PCR master mix
(Abgene) and the following primers (sequence from homology arm
is underlined; RpsL-neo sequences are italicised): ETM56F (5′-
CCGCTGTCGGGAGAGAAAACCGTTCATAATTTTGGAAACCGCCTCCAAA-
CACGGCCTGGTGATGATGGCGGGATC-3′) and ETM56R (5′-GGGAA-
GACCTCGAGGACGTTTTCACTCTGGGCGAGGGGCGCTTCGGGGGCGTCA-
CAGAAGAACTCGTCAAGAAGGCG-3′); ETM70F (5′-TGACGCAAGCAGGAT-
GCGTGGGTGCGCTGCCGGAACGGGGGTCGTCGTCGCCGGCCTGGTGAT-
GATGGCGGGATC-3′) and ETM70R (5′-CGTCTGCCGCTCGGGCCCCTGCT-
GCGAGCGCACCTGTCGCTCGAGTCGGGATCAGAAGAACTCGTCAAGAAGGC-
G-3′); ETM98F (5′-GCAGTGCGAATCCGCGATCGCGCAGGTGCTCAGGG-
AGTTCGTGGCCGAGGGGGGCCTGGTGATGATGGCGGGATC-3′) and
ETM98R (5′-GCCTTGAGGAACAGATCTAGGTAGAGCGGGGGCCGCTCG-
GCGGACAGGATGTCAGAAGAACTCGTCAAGAAGGCG-3′). PCR products
were digested with DpnI (NEB) to remove any residual template
DNA.
PCR fragments (100–200 ng in 1–2 μl of water) were added to the
cells. Electroporationwas performedusing a 1mmgap ice-cold cuvette
and a Bio-Rad Gene Pulser set to 25 μF, 2.3 kV with pulse controller set
at 200 Ω. LB medium (1 ml) was added immediately after electro-
poration. The cells were incubated at 30 °C for 2–3 h with shaking,
spread on plates containing 12 μg ml−1 chloramphenicol, 20 μg ml−1
kanamycin and 50 μgml−1 carbenicillin and grown at 30 °C overnight.
To identify recombinants, colonieswere restreaked inparallel onplates
containing 12 μg ml−1 chloramphenicol plus 20 μg ml−1 kanamycin
and on plates containing 12 μgml−1 chloramphenicol plus 80 μgml−1
streptomycin. Recombinants were selected based on their chloram-
phenicol and kanamycin resistance and streptomycin sensitivity and
integration of the rpsL-neo cassette conﬁrmed by PCR.
A linear DNA fragment carrying a tsm5-speciﬁc nucleotide
substitution in the M56 (C to T at base position 86,783), M70 (C to T
at base position 99,286) or M98 (C to T at base position 143,114) gene
was ampliﬁed by PCR from tsm5 or the chimaeric Smith/tsm5DGIK
(Sweet et al., 2007) viral DNA template using Extensor Hi-Fidelity PCR
master mix (Abgene) and the following primers: M56F (5′-
GTGTCTGTCGAGATAGTGG-3′) and M56R (5′-CTGTTTTCAGTGCTAC-
GAGG-3′); M70F (5′-GTCCGCAGCATGGTTTCGCC-3′) and M70R (5′-
GCCGGCATCCTCGATCACAC-3′); M98F (5′-GAGAGCACCGTCAGA-
GATGC-3′) and M98R (5′-TCAGGGAGTCCGCGGCGTAG-3′). These PCR
products were used to replace the rpsL-neo cassette as described
above. Recombinants were replica plated as above and suitable
colonies selected based on their chloramphenicol and streptomycin
resistance and kanamycin sensitivity. Recombinant BAC plasmid DNA,
isolated using the NucleoBond® BAC kit (Macherey-Nagel), was PCR
screened and sequenced to conﬁrm themutatedMCMVBAC. TheM56,
M70 and M98 gene-speciﬁc mutated BAC MCMVs were transfected
into NIH 3T3 cells using ExGen500 in vitro transfection reagent
(Fermentas) to generate MCMV mutant viruses MtM56G439R (hence-
forth referred to as Mt56439R), MtM70C890Y (Mt70890Y), MtM98P324S
(Mt98324S) , MtM98P324SM70C890Y (Mt98324S70890Y) and
MtM98P324SM70C890YM56G439R (Mt98324S70890Y56439R).
To rescue the above mutants to wt, a further two-step Red-
mediated recombination was performed as above. First the rpsL-neo
cassettewas inserted into themutantMCMVBACDNA and second, the
rpsL-neo cassette was replaced by linear wt DNA sequence. Revertant
BAC DNAs were identiﬁed by PCR and transfected into NIH 3T3 cells togenerate the MCMV revertant viruses Rv56G439, Rv70C890, Rv98P324,
Rv98P32470C890 and Rv98P32470C89056G439.
Virus replication in vitro
MEF cells, seeded into 24 well plates (Corning) at 1×105 cells per
well 24 h before virus infection, were inoculated at an MOI of 0.05 pfu
per cell. After 1 h incubation the inoculumwas removed and the cells
were overlaid with 1 ml of growth medium. At 0–9 (in some
experiments 0–21) days p.i., culture ﬂuids were harvested and titrated
for virus.
Virus replication in animals
Speciﬁc pathogen-free 3-week-old immunocompetent BALB/c
mice (Charles River, UK) were inoculated intraperitoneally with
104 pfu of virus. Infected animals were sacriﬁced at 21 days p.i.,
salivary glands harvested, homogenised in growth medium, centri-
fuged and supernatants titrated for virus.
RFLP analysis
BAC DNA was isolated using BACMAX DNA Puriﬁcation Kit
(Epicentre), according to the manufacturer's instructions. BAC DNA
(1.5–3.5 μg) was digested with appropriate restriction enzyme and
separated on 0.4% agarose gels. Electrophoresis was carried out in
0.5×TBE buffer at a voltage of 20 V for 19–20 h. GelRed (Biotium)
stained DNA fragments were visualised under UV light in a transillu-
minator, and gel images were recorded using a UVP digital camera.
Statistical analysis
Virus titres and genome copy numbers were log10-transformed
and processed using the computer program Minitab 15 (Minitab
Ltd.). MCMV genome copies and virus titres in salivary glands of
virus-infected BALB/c mice were compared using non-parametric
Mann–Whitney U-test. Results were considered to be signiﬁcantly
different when P b0.05 was achieved. Values reported represent
mean±standard deviation (SD).Acknowledgments
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